205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
12.28%
Revenue growth above 1.5x AVGO's 7.09%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
13.83%
Gross profit growth under 50% of AVGO's 70.36%. Michael Burry would be concerned about a severe competitive disadvantage.
24.58%
EBIT growth below 50% of AVGO's 73.63%. Michael Burry would suspect deeper competitive or cost structure issues.
24.89%
Operating income growth under 50% of AVGO's 73.63%. Michael Burry would be concerned about deeper cost or sales issues.
18.19%
Net income growth under 50% of AVGO's 74.87%. Michael Burry would suspect the firm is falling well behind a key competitor.
23.46%
EPS growth under 50% of AVGO's 74.90%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
24.05%
Diluted EPS growth under 50% of AVGO's 75.48%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.22%
Share reduction while AVGO is at 1.02%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
0.10%
Diluted share reduction more than 1.5x AVGO's 0.96%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
0.22%
Dividend growth under 50% of AVGO's 2.39%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
32.18%
OCF growth at 50-75% of AVGO's 54.82%. Martin Whitman would question if the firm lags in monetizing sales effectively.
39.85%
FCF growth 50-75% of AVGO's 57.54%. Martin Whitman would see if structural disadvantages exist in generating free cash.
46.99%
10Y revenue/share CAGR under 50% of AVGO's 366.79%. Michael Burry would suspect a lasting competitive disadvantage.
21.16%
5Y revenue/share CAGR under 50% of AVGO's 290.65%. Michael Burry would suspect a significant competitive gap or product weakness.
24.02%
3Y revenue/share CAGR under 50% of AVGO's 268.76%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
407.30%
10Y OCF/share CAGR at 50-75% of AVGO's 767.35%. Martin Whitman might fear a structural deficiency in operational efficiency.
41.89%
Below 50% of AVGO's 180.86%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
34.40%
3Y OCF/share CAGR under 50% of AVGO's 340.21%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
107.43%
Positive 10Y CAGR while AVGO is negative. John Neff might see a substantial advantage in bottom-line trajectory.
84.05%
Positive 5Y CAGR while AVGO is negative. John Neff might view this as a strong mid-term relative advantage.
68.48%
Positive short-term CAGR while AVGO is negative. John Neff would see a clear advantage in near-term profit trajectory.
28.66%
Equity/share CAGR of 28.66% while AVGO is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
6.60%
Below 50% of AVGO's 546.89%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
1.90%
Below 50% of AVGO's 347.37%. Michael Burry suspects a serious short-term disadvantage in building book value.
1149.23%
Dividend/share CAGR of 1149.23% while AVGO is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
194.94%
Below 50% of AVGO's 495.80%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
35.78%
Below 50% of AVGO's 154.12%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
7.34%
AR growth is negative/stable vs. AVGO's 17.45%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
-3.62%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
3.33%
Positive asset growth while AVGO is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
3.48%
Positive BV/share change while AVGO is negative. John Neff sees a clear edge over a competitor losing equity.
-0.03%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
3.52%
R&D growth drastically higher vs. AVGO's 3.43%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-2.64%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.